GFG Capital’s CVS Health CVS Stock Holding History

GFG Capital’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-9,000	Closed	-$534K	–	95
2020 Q1	$534K	Buy	+9,000	New	+$601K	0.27%	43

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

GFG Capital's CVS Position: Q2 2020 in Review

GFG Capital sold out of CVS Health (CVS) in Q2 2020, closing a stake of 9,000 shares — an estimated $534K sold.

GFG Capital first reported a position in CVS in Q1 2020 and held it in 1 quarter. The position peaked at $534K in Q1 2020. 1,864 funds tracked by Wall St. Rank hold CVS as of Q2 2020.

GFG Capital reported no remaining CVS Health position as of Q2 2020 after selling out during the quarter.
GFG Capital sold 9,000 CVS Health shares in Q2 2020, an estimated $534K.
GFG Capital first reported a position in CVS Health in Q1 2020 and held it in 1 quarter.
GFG Capital's CVS Health position peaked at $534K in Q1 2020.
1,864 funds tracked by Wall St. Rank held CVS Health as of Q2 2020.

Based on GFG Capital's 13F filing for Q2 2020, filed 17 Jul 2020.